The tariff classification of blood glucose monitors from South Korea
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated July 14, 2025, on behalf of your client, i-SENS USA, Inc., you requested a tariff classification ruling. Descriptive literature was provided for our review.
The items under consideration are described as blood glucose monitors identified as the CareSens N Blood Glucose Monitoring Basic (part number 164301-202), the CareSens N Feliz Blood Glucose Monitoring Basic (part number 164503), the CareSens N Feliz BT Blood Glucose Monitoring Basic Kit (part number 164508), and the CareSens N Voice Blood Glucose Monitoring Basic Kit (part number 312442). The glucose monitors are all very similar with only a few additional features such as Bluetooth capability or voice commands.
The blood glucose monitors operate by using a disposable blood glucose test strip which is inserted into the blood glucose monitor. After inserting the test strip, the user applies a small sample of blood obtained using a lancing device to the test strip, which produces an electrochemical signal in proportion to the glucose concentration in the blood sample.
The meters measure this signal using dynamic electrochemistry to measure blood glucose levels and correct for common analytical interferents such as hematocrit. The results are displayed on the attached screen.
The blood glucose monitoring kits contain a standard set of components, which includes a blood glucose monitor (a device used by persons afflicted with diabetes to measure the glucose levels in blood), a carrying case (a protective container designed to carry and store diabetes supplies), an owner’s guide (instructions for use), and two CR2032 batteries (power the blood glucose monitor).
General Rule of Interpretation (GRI) 1, Harmonized Tariff Schedule of the United States (HTSUS), states in part that for legal purposes, classification shall be determined according to the terms of the headings and any relative section or chapter notes. Goods that are, prima facie, classifiable under two or more headings, are classifiable in accordance with GRI 3, HTSUS.
GRI 3(a) states, in part, that when two or more headings each refer to a part of the items in a set put up for retail sale, those headings are to be regarded as equally specific, even if one heading gives a more precise description of the good. The instant goods consist of at least two different articles that are, prima facie, classifiable in different subheadings. It consists of articles put up together to carry out a specific activity (i.e., blood glucose testing).
Finally, the articles are put up in a manner suitable for sale directly to users without repacking. Therefore, the goods in question are within the term “goods put up in sets for retail sale.” GRI 3(b) states, in part, that goods put up in sets for retail sale, which cannot be classified by reference to GRI 3(a), are to be classified as if they consisted of the component which gives them their essential character.
It is the opinion of this office that the essential character of the blood glucose monitoring kits is imparted by the blood glucose monitor.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N351313).